Literature DB >> 28797748

Renal trials in diabetes need a platform: time for a global approach?

Dick de Zeeuw1, Hiddo J L Heerspink2, Meg Jardine3, Vlado Perkovic4.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28797748     DOI： 10.1016/S2213-8587(17)30263-2

Source DB:  PubMed          Journal:  Lancet Diabetes Endocrinol        ISSN： 2213-8587            Impact factor:   32.069


× No keyword cloud information.
  4 in total

1.  Time for clinical decision support systems tailoring individual patient therapy to improve renal and cardiovascular outcomes in diabetes and nephropathy.

Authors:  Dick de Zeeuw; Hiddo J L Heerspink
Journal:  Nephrol Dial Transplant       Date:  2020-03-01       Impact factor: 5.992

Review 2.  Kidney disease trials for the 21st century: innovations in design and conduct.

Authors:  William G Herrington; Natalie Staplin; Richard Haynes
Journal:  Nat Rev Nephrol       Date:  2019-10-31       Impact factor: 28.314

Review 3.  Scientific Advances in Diabetes: The Impact of the Innovative Medicines Initiative.

Authors:  Maria de Fátima Brito; Carla Torre; Beatriz Silva-Lima
Journal:  Front Med (Lausanne)       Date:  2021-07-06

4.  Baseline characteristics and enrichment results from the SONAR trial.

Authors:  Hiddo J L Heerspink; Dennis L Andress; George Bakris; John J Brennan; Ricardo Correa-Rotter; Fan Fan Hou; Dalane W Kitzman; Donald Kohan; Hirofumi Makino; John McMurray; Vlado Perkovic; Sheldon Tobe; Melissa Wigderson; Tingting Yi; Hans-Henrik Parving; Dick de Zeeuw
Journal:  Diabetes Obes Metab       Date:  2018-05-01       Impact factor: 6.577
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.